NCT06943157

Brief Summary

This descriptive study aims to examine the relationship between self-efficacy and medication adherence in individuals with coronary artery disease (CAD). The study will be conducted between March and October 2025 at Adıyaman University Training and Research Hospital with a planned sample size of 135 participants. Data will be collected using a Descriptive Information Form, the Self-Efficacy for Managing Chronic Disease Scale, and the Medication Adherence Report Scale (MARS).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
135

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 17, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 24, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

April 27, 2025

Status Verified

March 1, 2025

Enrollment Period

7 months

First QC Date

April 17, 2025

Last Update Submit

April 24, 2025

Conditions

Keywords

NurseCoronary Artery DiseaseSelf-EfficacyMedication Adherence

Outcome Measures

Primary Outcomes (1)

  • Self-efficacy score for chronic disease management

    Self-efficacy levels of patients with coronary artery disease will be measured using the 6-Item Self-Efficacy Scale for Chronic Disease Management. Each item is rated from 1 to 10. The total score ranges from 6 to 60, and higher scores indicate better self-efficacy in chronic disease management.

    At the time of data collection (March 2025 - October 2025)

Secondary Outcomes (1)

  • Medication adherence score

    At the time of data collection (March 2025 - October 2025)

Study Arms (1)

Coronary Artery Disease Patients

This cohort consists of individuals aged 18 and older who have been diagnosed with coronary artery disease for at least one year and are being followed in cardiology or cardiovascular surgery outpatient or inpatient clinics. Patients included are those who volunteered to participate in the study, can communicate in Turkish, and do not have any mental disorders.

Other: No intervention

Interventions

This is a descriptive, observational study. No intervention or experimental procedure was performed. Data were collected using self-administered questionnaires without influencing participant behavior or treatment.

Coronary Artery Disease Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of individuals aged 18 and older who have been diagnosed with coronary artery disease for at least one year and are being followed in cardiology or cardiovascular surgery outpatient/inpatient clinics at Adıyaman University Training and Research Hospital. All participants must be able to communicate in Turkish, have no diagnosed mental disorder, and voluntarily agree to participate in the study.

You may qualify if:

  • Being 18 years of age or older
  • Having been diagnosed with Coronary Artery Disease (angina pectoris, unstable angina, myocardial infarction) at least 1 year ago
  • Being followed
  • Being able to communicate in Turkish
  • Voluntarily agreeing to participate in the study
  • Having no diagnosed mental disorder

You may not qualify if:

  • Having a primary diagnosis other than Coronary Artery Disease
  • Being unable to complete the questionnaires due to mental health problems
  • Providing incomplete data or withdrawing from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adiyaman University Training and Research Hospital

Adıyaman, 02040, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • Fors A, Ulin K, Cliffordson C, Ekman I, Brink E. The Cardiac Self-Efficacy Scale, a useful tool with potential to evaluate person-centred care. Eur J Cardiovasc Nurs. 2015 Dec;14(6):536-43. doi: 10.1177/1474515114548622. Epub 2014 Aug 22.

    PMID: 25149667BACKGROUND

MeSH Terms

Conditions

Coronary Artery DiseaseMedication Adherence

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Central Study Contacts

ZEYNAL KİZİR, PhD Student

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student, Hasan Kalyoncu University, Faculty of Health Sciences, Nursing Department

Study Record Dates

First Submitted

April 17, 2025

First Posted

April 24, 2025

Study Start

March 1, 2025

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

April 27, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

This study does not plan to share individual participant data (IPD).

Locations